Triesence 40 mg/ ml Norwe - Kinorwe - Statens legemiddelverk

triesence 40 mg/ ml

novartis norge as - triamcinolonacetonid - injeksjonsvæske, suspensjon - 40 mg/ ml

Tobrasone 3 mg/ ml / 1 mg/ ml Norwe - Kinorwe - Statens legemiddelverk

tobrasone 3 mg/ ml / 1 mg/ ml

novartis norge as - tobramycin / deksametason - Øyedråper, suspensjon - 3 mg/ ml / 1 mg/ ml

Tobrex Depot 3 mg/ ml Norwe - Kinorwe - Statens legemiddelverk

tobrex depot 3 mg/ ml

novartis norge as - tobramycin - depotøyedråper, oppløsning - 3 mg/ ml

Zofran 16 mg Norwe - Kinorwe - Statens legemiddelverk

zofran 16 mg

novartis norge as - ondansetronhydroklorid - stikkpille - 16 mg

Beovu Umoja wa Ulaya - Kinorwe - EMA (European Medicines Agency)

beovu

novartis europharm limited  - brolucizumab - wet macular degeneration - Øyemidler - beovu er angitt i voksne for behandling av neovascular (våt) aldersrelatert makuladegenerasjon (amd).

Leqvio Umoja wa Ulaya - Kinorwe - EMA (European Medicines Agency)

leqvio

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipid modifiserende midler - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Tabrecta Umoja wa Ulaya - Kinorwe - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karsinom, ikke-småcellet lunge - antineoplastiske midler - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Azarga Umoja wa Ulaya - Kinorwe - EMA (European Medicines Agency)

azarga

novartis europharm limited - brinzolamide, timolol maleate - glaucoma, open-angle; ocular hypertension - Øyemidler - reduksjon av intraokulært trykk (iop) hos voksne pasienter med åpen vinkelglukom eller økt hypertensjon for hvem monoterapi gir utilstrekkelig iop reduksjon.

Copalia Umoja wa Ulaya - Kinorwe - EMA (European Medicines Agency)

copalia

novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - hypertensjon - agenter som virker på renin-angiotensinsystemet - behandling av essensiell hypertensjon. copalia er indisert hos pasienter hvor blodtrykket ikke er tilstrekkelig kontrollert på amlodipine eller valsartan monoterapi.